Stonepine Capital Management, LLC
Annual return '25
+0.4%
SPY '25
+17.7%
Alpha
-17.3ptsvs SPY
Invested
$197.7M
Holdings
73
Trades YTD
0
Performance · Fund vs SPY
Cumulative return · quarterly snapshotsCoverage 100%. 3 quarters of 2025 measured against SPY adj-close benchmark.
Top holdings · current snapshot
Source: 13F-HR01
$XBI
SPDR SERIES TRUST
Held since at least Q1 2024
25.8%
02
$VSTM
VERASTEM INC
Q4 2025: Exited (was 2.67M shares)
8.9%
03
$ADMA
ADMA BIOLOGICS INC
Q4 2025: Exited (was 739.0k shares)
8.6%
04
$TENX
TENAX THERAPEUTICS INC
Held since at least Q1 2024
7.9%
05
$EOLS
EVOLUS INC
Q4 2025: Exited (was 1.54M shares)
4.5%
06
$CAMP
CAMP4 THERAPEUTICS CORP
Held since at least Q1 2024
3.1%
07
$NKTR
NEKTAR THERAPEUTICS
Q4 2025: Exited (was 85.0k shares)
3.1%
08
$TERN
TERNS PHARMACEUTICALS INC
Held since at least Q1 2024
2.7%
09
$ZVRA
ZEVRA THERAPEUTICS INC
Q4 2025: Exited (was 810.0k shares)
2.3%
10
$ABEO
ABEONA THERAPEUTICS INC
Q4 2025: Exited (was 451.0k shares)
1.9%
Recent trades · Last 90 days
No Form 4 / 13D / 13G trade events on file in the recent window. 13F filers report position snapshots quarterly rather than per-trade events, so this section is most useful for managers who also file Form 4 or 13D/G.
Convergence · Pattern Engine ships in v1.1
30-day windowIn development
Convergence participation lands with the Pattern Engine.
Once the Pattern Engine ships, this section will list every active convergence event this fund is named in — with the other named funds, the Congress members on the same name, and combined position size.
Source data: SEC EDGAR · 13F-HR filings · Performance through 2025-12-31 · Last refreshed 12:52 UTC.